Targeting cellular response to SARS-CoV-2 holds promise as new way to fight infection
17 June 2021
A new treatment approach focused on fixing cell damage, rather than fighting the virus directly, is effective against SARS-CoV-2 in lab models. If found safe for human use, this anti-viral treatment would make COVID-19 symptoms milder and speed up recovery times.
Apollo Therapeutics launches with £100m investment
17 June 2021
Pioneering collaboration initiated by the University of Cambridge, Imperial College London and University College London
Study identifies trigger for ‘head-to-tail’ axis development in human embryo
17 June 2021
Scientists have identified key molecular events in the developing human embryo between days 7 and 14 - one of the most mysterious, yet critical, stages of our development.
© 2021 University of Cambridge
